These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27913435)

  • 1. IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
    Chiang S; Weigelt B; Wen HC; Pareja F; Raghavendra A; Martelotto LG; Burke KA; Basili T; Li A; Geyer FC; Piscuoglio S; Ng CK; Jungbluth AA; Balss J; Pusch S; Baker GM; Cole KS; von Deimling A; Batten JM; Marotti JD; Soh HC; McCalip BL; Serrano J; Lim RS; Siziopikou KP; Lu S; Liu X; Hammour T; Brogi E; Snuderl M; Iafrate AJ; Reis-Filho JS; Schnitt SJ
    Cancer Res; 2016 Dec; 76(24):7118-7129. PubMed ID: 27913435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.
    Lozada JR; Basili T; Pareja F; Alemar B; Paula ADC; Gularte-Merida R; Giri DD; Querzoli P; Cserni G; Rakha EA; Foschini MP; Reis-Filho JS; Brogi E; Weigelt B; Geyer FC
    Histopathology; 2018 Aug; 73(2):339-344. PubMed ID: 29603332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.
    Pareja F; da Silva EM; Frosina D; Geyer FC; Lozada JR; Basili T; Da Cruz Paula A; Zhong E; Derakhshan F; D'Alfonso T; Wen HY; Giri DD; Hayes MM; Krings G; Bhargava R; Palazzo JP; Rakha EA; Hoda SA; Sanders ME; Collins LC; Schnitt SJ; Chen YY; Weigelt B; Jungbluth AA; Reis-Filho JS; Brogi E
    Mod Pathol; 2020 Jun; 33(6):1056-1064. PubMed ID: 31896809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases.
    Alsadoun N; MacGrogan G; Truntzer C; Lacroix-Triki M; Bedgedjian I; Koeb MH; El Alam E; Medioni D; Parent M; Wuithier P; Robert I; Boidot R; Arnould L
    Mod Pathol; 2018 Sep; 31(9):1367-1380. PubMed ID: 29785016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tall cell carcinoma of the breast with reversed polarity (TCCRP) with mutations in the IDH2 and PIK3CA genes: a case report.
    Haefliger S; Muenst S; Went P; Bihl M; Dellas S; Weber WP; Vlajnic T
    Mol Biol Rep; 2020 Jun; 47(6):4917-4921. PubMed ID: 32474846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tall Cell Carcinoma with Reverse Polarity of Breast: Report of a Case with Unique Morphologic and Molecular Features.
    Jassim M; Premalata CS; Okaly G; Srinivas C
    Turk Patoloji Derg; 2021; 37(2):183-188. PubMed ID: 33021737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast.
    Troxell ML; Levine J; Beadling C; Warrick A; Dunlap J; Presnell A; Patterson J; Shukla A; Olson NR; Heinrich MC; Corless CL
    Mod Pathol; 2010 Jan; 23(1):27-37. PubMed ID: 19898424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic papillary and lobular breast carcinoma with PIK3CA and IDH1 mutations.
    Ang D; VanSandt AM; Beadling C; Warrick A; West RB; Corless CL; Troxell ML
    Diagn Mol Pathol; 2012 Dec; 21(4):221-4. PubMed ID: 23111200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular evaluation of PIK3CA gene mutation in breast cancer: determination of frequency, distribution pattern and its association with clinicopathological findings in Indian patients.
    Ahmad F; Badwe A; Verma G; Bhatia S; Das BR
    Med Oncol; 2016 Jul; 33(7):74. PubMed ID: 27282497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Tumor Resembling the Tall Cell Variant of Papillary Thyroid Carcinoma: Molecular Characterization by Next-Generation Sequencing and Histopathological Comparison With Tall Cell Papillary Carcinoma of Thyroid.
    Zhong E; Scognamiglio T; D'Alfonso T; Song W; Tran H; Baek I; Hoda SA
    Int J Surg Pathol; 2019 Apr; 27(2):134-141. PubMed ID: 30227763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Diagnostic Utility of IDH2 R172 Immunohistochemistry in Tall Cell Carcinoma With Reversed Polarity of the Breast.
    Sasaki E; Iwakoshi A; Satake T; Nakajima K; Kobayashi M; Ando Y; Koshikawa T; Masago K; Honma N; Nishimura R; Kato Y; Ichihara S
    Appl Immunohistochem Mol Morphol; 2022 Nov-Dec 01; 30(10):654-661. PubMed ID: 36222504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer.
    Rothé F; Laes JF; Lambrechts D; Smeets D; Vincent D; Maetens M; Fumagalli D; Michiels S; Drisis S; Moerman C; Detiffe JP; Larsimont D; Awada A; Piccart M; Sotiriou C; Ignatiadis M
    Ann Oncol; 2014 Oct; 25(10):1959-1965. PubMed ID: 25185240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of encapsulated papillary carcinoma of the breast with and without invasion.
    Schwartz CJ; Boroujeni AM; Khodadadi-Jamayran A; Heguy A; Snuderl M; Jour G; Cotzia P; Darvishian F
    Hum Pathol; 2021 May; 111():67-74. PubMed ID: 33667422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variants.
    Dogan S; Frosina D; Geronimo JA; Hernandez E; Mohanty A; Bale T; Hechtman JF; Arcila ME; Hameed MR; Jungbluth AA
    Hum Pathol; 2020 Dec; 106():45-53. PubMed ID: 33017591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIK3CA-AKT pathway mutations in micropapillary breast carcinoma.
    Flatley E; Ang D; Warrick A; Beadling C; Corless CL; Troxell ML
    Hum Pathol; 2013 Jul; 44(7):1320-7. PubMed ID: 23352210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
    Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
    J Pathol; 2017 Aug; 242(4):400-408. PubMed ID: 28493366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
    Shah V; Nowinski S; Levi D; Shinomiya I; Kebaier Ep Chaabouni N; Gillett C; Grigoriadis A; Graham TA; Roylance R; Simpson MA; Pinder SE; Sawyer EJ
    Breast Cancer Res; 2017 Jan; 19(1):7. PubMed ID: 28095868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Insights of Pathways Resulting from Two Common PIK3CA Mutations in Breast Cancer.
    Bhat-Nakshatri P; Goswami CP; Badve S; Magnani L; Lupien M; Nakshatri H
    Cancer Res; 2016 Jul; 76(13):3989-4001. PubMed ID: 27197157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tall cell carcinoma of the breast with reversed polarity - a report of three cases with a review of the literature.
    Kajo K; Ducár M; Dzuracký J; Macháleková KK; Vallová M; Biró C; Šebest L; Slamka T; Lohajová RB; Žúbor P
    Cesk Patol; 2023; 59(3):132-138. PubMed ID: 38756088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma.
    Jo VY; Chau NG; Hornick JL; Krane JF; Sholl LM
    Mod Pathol; 2017 May; 30(5):650-659. PubMed ID: 28084339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.